Skip to main content
Publications
Huisman MV, Rothman KJ , Paquette M, Teutsch C, Diener HC, Dubner SJ, Halperin JL, Marin C, Ma CS, Zint K, Elsaesser A, Baretls DB, Lip GY. Antithrombotic treatment patterns in 10,871 patients with newly diagnosed non-valvular atrial fibrillation: the GLORIA-AF Registry Program, Phase II . Am J Med. 2015 Dec;128(12):1303-1313. doi: 10.1016/j.amjmed.2015.07.013
Wise LA, Rothman KJ , Mikkelsen EM, Stanford JB, Wesselink AK, McKinnon C, Gruschow SM, Horgan CE, Wiley AS, Hahn KA, Sørensen HT, Hatch EE. Design and conduct of an internet-based preconception cohort study in North America: pregnancy study online . Paediatr Perinat Epidemiol. 2015 Jul;29(4):360-71. doi: 10.1111/ppe.12201
Tennis P, Chan KA, Curkendall SN, Li DK, Mines D , Peterson C, Andrews EB, Calingaert B , Chen HY, Deshpande G, Everage N, Holick CN, Meyer NM, Nkhoma ET, Quinn S, Rothman KJ , Esposito DB. Topiramate use during pregnancy and major congenital malformations in multiple populations . Birth Defects Res Part A Clin Mol Teratol. 2015 Apr;103(4):269-75. doi: 10.1002/bdra.23357.
Kimball AB, Rothman KJ , Kricorian G, Pariser D, Yamauchi PS, Menter A, Teller CF, Aras G, Accortt NA, Hooper M, Rice KC, Gelfand JM. OBSERVE-5: observational postmarketing safety surveillance registry of etanercept for the treatment of psoriasis final 5-year results . J Am Acad Dermatol. 2015 Jan;72(1):115-22. doi: 10.1016/j.jaad.2014.08.050
Rothman KJ , Huisman M, Lip G, Diener H, Dubner S, Ma C, Zint C, Teutsch C, Shoof N, Paquette M, Kleine E, Bartels D, Halperin J, the GLORIA AT study team . Use of propensity scores to assess comparability of treatment groups in a registry program . Presented at the 30th International Conference on Pharmacoepidemiology and Therapeutic Risk Management; October 25, 2014. Taipei, Taiwan.
Mines D , Tennis P, Curkendall SM, Li DK, Peterson C, Andrews EB, Calingaert B , Chen H, Deshpande G, Esposito DB, Everage N, Holick CN, Meyer NM, Nkhoma ET, Quinn S, Rothman KJ , Chan KA. Topiramate use in pregnancy and the birth prevalence of oral clefts . Pharmacoepidemiol Drug Saf. 2014 Oct 1;23(10):1017-25. doi: 10.1002/pds.3612
Long A, Rahmaoui A, Rothman KJ , Guinan E, Eisner M, Bradley MS, Iribarren C, Chen H, Carrigan G, Rosén K, Szefler S. Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab . J Allergy Clin Immunol Pract. 2014 Sep;134(3):560-567.e. doi: 10.1016/j.jaci.2014.02.007
Vinceti M, Malagoli C, Rothman KJ , Rodolfi R, Astolfi G, Calzolari E, Puccini A, Bertolotti M, Lunt M, Paterlini L, Martini M, Nicolini F. Risk of birth defects associated with maternal pregestational diabetes . Eur J Epidemiol. 2014 Jun;29(6):411-8.
Kaye JA, Castellsague J, Bui CL , Calingaert B , McQuay LJ, Riera-Guardia N , Saltus CW , Quinlan S, Holick CN, Wahl PM, Suzart K, Rothman KJ , Wallander M-A, Perez-Gutthann S . Risk of acute liver injury associated with the use of moxifloxacin and other oral antimicrobials: a retrospective, population-based cohort study . Pharmacotherapy. 2014 Apr;34(4):336-49. doi: 10.1002/phar.1367
Cole JA, Elbert A, Haas J, Hewitt K, Bertagna Leavy M, Marshall BC, Rothman KJ , Tarver M. Modifying and Stopping Registries. In: Gliklich RE, Dreyer NA, Leavy MB, editors. Registries for evaluating patient outcomes: a user's guide . 3rd edition ed. Rockville: MD. Agency for Healthcare Research and Quality; 2014.
Huisman MV, Lip GY, Diener HC, Dubner SJ, Halperin JL, Ma CS, Rothman KJ , Teutsch C, Zint K, Ackermann D, Clemens A, Bartels DB. Design and rationale of global registry on long-term oral antithrombotic treatment in patients with atrial fibrillation: a global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation . Am Heart J. 2014 Mar;167(3):329-34. doi: 10.1016/j.ahj.2013.12.006
Bui CL , Kaye JA, Castellsague J, Calingaert B , McQuay LJ, Riera-Guardia N , Saltus CW , Quinlan SC, Holick CN, Wahl PM, Suzart K, Rothman KJ , Wallander MA, Perez-Gutthann S . Validation of acute liver injury cases in a population-based cohort study of oral antimicrobial users . Curr Drug Saf. 2014 Mar;9(1):23-8.
Long MD, Hutfless S, Kappelman MD, Khalili H, Kaplan GG, Bernstein CN, Colombel JF, Gower-Rousseau C, Herrinton L, Velayos F, Loftus EVJr, Ananthakrishnan AN, Nguyen GC, Sonnenberg A, Chan A, Sandler RS, Atreja A, Shah SA, Rothman KJ , Leleiko NS, Bright R, Boffetta P, Myers KD, Sands BE. Challenges in designing a national surveillance program for inflammatory bowel disease in the United States . Inflamm Bowel Dis. 2014 Feb;20(2):398-415. doi: 10.1097/01.MIB.0000435441.30107.8b
Villa M, Black S, Groth N, Rothman KJ , Apolone G, Weiss NS, Aquino I, Boldori L, Caramaschi F, Gattinoni A, Malchiodi G, Crucitti A, Della Cioppa G, Scarpini E, Mavilio D, Mannino S. Safety of mf59-adjuvanted influenza vaccination in the elderly: results of a comparative study of mf59-adjuvanted vaccine versus nonadjuvanted influenza vaccine in northern Italy . Am J Epidemiol. 2013 Oct;178(7):1139-45.
Toh S, Avorn J, D'Agostino RB, Gurwitz JH, Psaty BM, Rothman KJ , Saag KG, Sturkenboom MCJM, Vandenbroucke JP, Winterstein AG, Strom BL. Re-using Mini-Sentinel data following rapid assessments of potential safety signals via modular analytic programs . Pharmacoepidemiol Drug Saf. 2013 Oct;22(10):1036-45.